Skip to content
Open access

De novo design of selective kinase modulators

Jul 2026 · bioRxiv · 0 citations · 9 references
Biology Medicine

Abstract

Protein kinases are critical regulators of cellular signaling, but precise modulation of their activity remains challenging due to their high structural conservation. Here, we present de novo designed genetically encoded miniproteins capable of activating or inhibiting focal adhesion kinase (FAK) by directly targeting the kinase domain itself. Among 96 binders designed to stabilize distinct conformational states of FAK, 33 modulated kinase activity. Biochemical characterization of the four most potent modulators revealed that two designs inhibit FAK with low-nanomolar IC50 values while the remaining two potentiated FAK activity by more than two-fold. When expressed in cells, the modulators preserved the same inhibitory and activating effects observed in vitro, establishing that designed conformational binders can directly tune FAK signaling in living cells. Taking advantage of the high similarity between kinases, we redesigned the FAK inhibitors to inhibit Src kinase. Our approach establishes a versatile platform for selective and genetically encoded kinase control as a way to rewire cell signaling and as a starting point for the discovery of novel modulatory sites of kinases.

Read PDF

Similar papers

Review Open access Aug 2026

Beyond Kinase Inhibition: From Catalytic Blockade to Control of Protein Fate.

Together, these examples define an expanding pharmacological vocabulary for kinase drug discovery: one that asks not only whether a molecule inhibits its target kinase, but how ligand binding rewires protein stability, interactions, localisation, and function.

J. Diepeveen, Z. Kozicka · 0 citations
Review Aug 2026

Beyond the ATP-binding pocket: emerging strategies in kinase targeting from allosteric inhibition to targeted protein degradation.

The structural and medicinal chemistry principles underlying (i) allosteric inhibition and (ii) proximity-induced degradation are summarized, with an emphasis on design logic, structure-activity relationships, and key liabilities in the beyond rule of five space.

Mei Zhou, Linshan Li, Xiao-Juan Tang et al. · 0 citations
Open access Aug 2026

Small-Molecule-Mediated Depletion of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B (DYRK1B) Protein Scaffold

Members of the DYRK kinase family have been implicated in the regulation of key metabolic processes. In particular, DYRK1B plays a central role in hepatic lipid metabolism and fatty liver disease. Notably, these functions depend not only on the enzyme’s catalytic activity but also on scaffolding properties. Consequentl...

Miriam S. Ems, Mattias F. Lindberg, Till Adhikary et al. · 0 citations
Review Open access Aug 2026

Kinase cascades: emerging design principles and guidelines

It is proposed that the order of kinases in cascades is dictated by their conformational character, a mechanism amplified in cascade-enriched biomolecular condensates—establishing design principles for pathway-selective, cascade-directed therapeutics.

R. Nussinov, Clil Regev, H. Jang · 0 citations
Sep 2026

Isoform-Selective Targeting of Akt Through Covalent Allosteric Inhibition.

Developing selective covalent-allosteric Akt inhibitors targeting Akt2 and Akt3 while sparing Akt1 is reported, which establishes a framework for the development of isoform-selective therapeutics and highlights the potential for unraveling isoform-specific functions in signaling pathways relevant to cancer biology.

G. D'Angelo, Kosmas Alexandros Pervanidis, Ioannis Athanasiadis et al. · 1 citation
Open access Sep 2026

Impact of Inhibitor Size and Flexibility on the Binding Pathways to c‑Src Kinase

It is shown that inhibitor size and flexibility affect binding mechanisms and have implications on kinetics, distinct from previous computational studies.

A. Shinobu, Suyong Re, Hiraku Oshima et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.